Translating molecular insights in autoimmunity into effective therapy

Marc Feldmann1

  • 1Kennedy Institute of Rheumatology Division, Imperial College London, London W6 8LH, UK. m.feldmann@imperial.ac.uk

Annual Review of Immunology
|November 15, 2008
PubMed
Summary

Research into autoimmunity and rheumatoid arthritis (RA) revealed that tumor necrosis factor (TNF) drives RA pathogenesis. Targeting TNF with monoclonal antibodies revolutionized RA treatment, highlighting cytokines as key therapeutic targets.

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...